How Should We Consider the Risk of Antineutrophil Cytoplasmic Antibody (ANCA)–Positive Small-Vessel Vascul itis Associated with Antithyroid Drug Therapy?

How Should We Consider the Risk of Antineutrophil Cytoplasmic Antibody (ANCA)–Positive Small-Vessel Vasculitis Associated with Antithyroid Drug Therapy?: Clinical Thyroidology Jan 2016, Vol. 28, No. 1: 18-21.

• Full Text HTML
• Full Text PDF (223.4 KB)
• Full Text PDF with Links (225.7 KB)

Author information

Jacques Orgiazzi
Balavoine AS, Glinoer D, Dubucquoi S, Wémeau JL. Antineutrophil cytoplasmic antibody-positive small-vessel vasculitis associated with antithyroid drug therapy: how significant is the clinical problem? Thyroid 2015;25:1273-81. Epub October 19 2015.

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1ROJShZ
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1QhcJto
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1OZaERT
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1Q8R6tl
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1Qhw4uE
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1ROZu55
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1OAgl59
via IFTTT